The tenth epilepsy research group seminar for ERGO took place at Bygdøystuene on October 24th. Thirty participants attended the meeting, including colleagues and collaborators from Odense University Hospital and University of Southern Denmark, from GliaLab, Institute of Basic Medical Sciences, University of Oslo, and from Norwegian Centre for Molecular Medicine.
Dear Colleagues
It is a great pleasure to welcome you all to the third Nordic status epilepticus meeting (3rd NSEM) to be held in Oslo, May 22-23, 2025. Status epilepticus is the most serious and most feared seizure type with still a high mortality and morbidity rate. Early and correct treatment is of utmost importance for outcome and long-term prognosis. This time, we will therefore focus on the prehospital and early phase. The overarching theme is therefore: “Time To Control – from basics to the clinic in status epilepticus” and the goal is to improve and standardize early status epilepticus treatment. We will also discuss factors involved in the development and maintenance of status epilepticus including autoimmunity, biomarkers and molecular mechanisms, and also touch upon the difficult problem with functional/dissociative seizures and status epilepticus.
We are proud to have some of the leading experts in the field both internationally and from the Nordic countries and look forward to two exciting days in Oslo in May 2025.
This is an independent scientific meeting sponsored by an unrestricted grant from Desitin Pharma. You can attend either in person or digitally and the meeting is free of charge.
We look forward to seeing you in Oslo in May 2025!
Erik Taubøll
Head of Organising committee and leader of ERGO
Department of Neurology
Oslo university hospital - Rikshospitalet
Norway